These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 11475270)

  • 1. Repaglinide dose response? A clinician's viewpoint.
    Schade DS
    Diabetes Technol Ther; 1999; 1(3):257-8. PubMed ID: 11475270
    [No Abstract]   [Full Text] [Related]  

  • 2. Repaglinide dose response? A clinician's viewpoint.
    Strange P; Goldberg RB
    Diabetes Technol Ther; 2000; 2(1):119-21. PubMed ID: 11467310
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetics, pharmacodynamics, and dose-response relationship of repaglinide in type 2 diabetes.
    Strange P; Schwartz SL; Graf RJ; Polvino W; Weston I; Marbury TC; Huang WC; Goldberg RB
    Diabetes Technol Ther; 1999; 1(3):247-56. PubMed ID: 11475269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repaglinide for type 2 diabetes mellitus.
    Med Lett Drugs Ther; 1998 May; 40(1027):55-6. PubMed ID: 9618664
    [No Abstract]   [Full Text] [Related]  

  • 5. Repaglinide: a novel oral antidiabetic agent.
    Nattrass M
    Hosp Med; 2000 Feb; 61(2):112-5. PubMed ID: 10748789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of rapid insulin secretion: revisited.
    Grodsky GM
    Diabetes Technol Ther; 1999; 1(3):259-60. PubMed ID: 11475271
    [No Abstract]   [Full Text] [Related]  

  • 7. Severe hypoglycaemia from repaglinide-brotizolam drug interaction: a case report and literature review.
    Khamaisi M
    Diabet Med; 2012 Sep; 29(9):1214-5. PubMed ID: 22414218
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prandial glucose regulator for type 2 diabetic patients. Beta cells produce insulin according to need].
    MMW Fortschr Med; 1999 Sep; 141(36):61. PubMed ID: 10904606
    [No Abstract]   [Full Text] [Related]  

  • 9. Insulin secretagogues.
    Kock M
    J Assoc Physicians India; 1997; Suppl 1():48. PubMed ID: 11235637
    [No Abstract]   [Full Text] [Related]  

  • 10. Differential lipid profile and hormonal response in type 2 diabetes by exogenous insulin aspart versus the insulin secretagogue repaglinide, at the same glycemic control.
    Chisalita SI; Lindström T; Eson Jennersjö P; Paulsson JF; Westermark GT; Olsson AG; Arnqvist HJ
    Acta Diabetol; 2009 Mar; 46(1):35-42. PubMed ID: 18777156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of repaglinide addition to NPH insulin monotherapy on glycemic control in patients with type 2 diabetes.
    de Luis DA; Aller R; Cuellar L; Terroba C; Ovalle H; Izaola O; Romero E
    Diabetes Care; 2001 Oct; 24(10):1844-5. PubMed ID: 11574456
    [No Abstract]   [Full Text] [Related]  

  • 12. [Repaglinide (NN-623)].
    Kaku K
    Nihon Rinsho; 1997 Nov; 55 Suppl():180-5. PubMed ID: 9434464
    [No Abstract]   [Full Text] [Related]  

  • 13. Repaglinide plus single-dose insulin glargine: a safe regimen for low-risk type 2 diabetic patients who insist on fasting in Ramadan.
    Bakiner O; Ertorer ME; Bozkirli E; Tutuncu NB; Demirag NG
    Acta Diabetol; 2009 Mar; 46(1):63-5. PubMed ID: 18825302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Repaglinide].
    Quast U
    Dtsch Med Wochenschr; 2001 May; 126(19):559-60. PubMed ID: 11402913
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mechanisms of action of repaglinide at a cellular level].
    Thomsen MK
    Diabetes Metab; 1999 Dec; 25 Suppl 7():11-3. PubMed ID: 10746004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy in type 2 diabetes: the role of repaglinide.
    Moses R
    J Assoc Physicians India; 2001 Jan; 49 Spec No():62-8. PubMed ID: 11235608
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of prandial glucose regulation with repaglinide in addressing the problem of hypoglycemia in the treatment of type 2 diabetes.
    Owens D
    J Assoc Physicians India; 2001 Jan; 49 Spec No():54-61. PubMed ID: 11235607
    [No Abstract]   [Full Text] [Related]  

  • 18. Meal-induced platelet activation in Type 2 diabetes mellitus: effects of treatment with repaglinide and glibenclamide.
    Yngen M; Ostenson CG; Hjemdahl P; Wallén NH
    Diabet Med; 2006 Feb; 23(2):134-40. PubMed ID: 16433710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Large general practice study with repaglinide. Fewer "anxiety eating" in diabetic patients].
    MMW Fortschr Med; 2001 Mar; 143(10):47-8. PubMed ID: 11277117
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical experience with repaglinide in patients with non-insulin-dependent diabetes mellitus.
    Shapiro MS; Abrams Z; Lieberman N
    Isr Med Assoc J; 2005 Feb; 7(2):75-7. PubMed ID: 15729954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.